FIELD: medicine; pharmaceuticals.
SUBSTANCE: liquid pharmaceutical suspension for oral administration, containing: a. a bismuth-containing pharmaceutical agent; b. a suspension system containing from about 0.01 wt. % to about 0.2 wt. % gellan gum and from about 0.01 wt. % to about 0.75 wt. % magnesium aluminium silicate; and c. water.
EFFECT: invention provides pharmaceutical suspensions characterised by improved rheological properties and physical stability.
18 cl, 1 dwg, 11 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING LIQUID PHARMACEUTICAL SUSPENSIONS CONTAINING BISMUTH | 2015 |
|
RU2694530C2 |
| COMPOSITION OF THE CULTURE MEDIUM AND METHOD OF CULTURING OF THE CELL OR TISSUE USING THE SPECIFIED COMPOSITION | 2013 |
|
RU2665793C2 |
| PHARMACEUTICAL COMPOSITION OF SILDENAFIL CITRATE IN FORM OF SUSPENSION FOR ORAL ADMINISTRATION | 2016 |
|
RU2649834C1 |
| LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | 2019 |
|
RU2783413C2 |
| NUTRITIVE EMULSION WITH INDUCED VISCOSITY | 2006 |
|
RU2465776C2 |
| LIQUID PRODUCT CONTAINING NUCLEOTIDES/NUCLEOSIDES | 2008 |
|
RU2446807C2 |
| STABILIZING COMPOSITION FOR BIOLOGICAL MATERIALS | 2013 |
|
RU2666601C2 |
| METHOD FOR OBTAINING PERSONAL CARE COMPOSITION WITH INTRODUCTION OF RHEOLOGY MODIFIER AT LATE STAGE | 2014 |
|
RU2671814C2 |
| LIQUID HAND DISHWASHING DETERGENT COMPOSITION | 2010 |
|
RU2494143C2 |
| THIXOTROPIC PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2470627C2 |
